Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.

232 Views15 Apr 2025 19:47
Issuer-paid
The 90-day pause in reciprocal tariffs was a short-lived reprieve for biopharma, as Trump later clarified pharma tariffs were not part of the pa
What is covered in the Full Insight:
  • Biopharma Market Performance
  • Impact of Pharma Tariffs
  • RFK Jr.'s Vaccine Comments
  • Company News and Stock Performance
  • Regulatory and Market Outlook
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
  • Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.
    15 Apr 2025
x